66 results
-
List item
Press release: Novartis withdraws its application to extend the marketing authorisation for Zometa
CHMP, Last updated: 20/11/2007pathological fractures, spinal compression, radiation or surgery to bone … pathological fractures, spinal compression, radiation or surgery to … -
List item
News: New treatment for people with dwarfism
CHMP, Last updated: 25/06/2021health complications, such as compression of the spinal cord, bowed … limb length, correct spinal compression or bowed legs. Most patients … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 May 2012
CHMP, Last updated: 25/05/2012pathological fractures, spinal compression, radiation or surgery to bone … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 June 2012
CHMP, Last updated: 22/06/2012pathological fractures, spinal compression, radiation or surgery to bone … -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 March 2017
European Medicines Agency, London, UK, from 20/03/2017 to 23/03/2017, Last updated: 20/03/2017 -
List item
Committee for Orphan Medicinal Products (COMP): 14-16 June 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 14/06/2022 to 16/06/2022, Last updated: 22/07/2022 -
List item
Press release: GVK Biosciences: European Medicines Agency recommends suspending medicines over flawed studies
CHMP, Last updated: 23/01/2015 -
List item
Committee for Orphan Medicinal Products (COMP): 7-9 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 07/12/2021 to 09/12/2021, Last updated: 06/12/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 3-5 November 2020
Virtual meeting, from 03/11/2020 to 05/11/2020, Last updated: 03/02/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 13-15 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 13/04/2021 to 15/04/2021, Last updated: 11/06/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 10-12 May 2021
European Medicines Agency, Amsterdam, the Netherlands, from 10/05/2021 to 12/05/2021, Last updated: 10/05/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 16-18 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 16/02/2021 to 18/02/2021, Last updated: 01/03/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 16-18 July 2019
European Medicines Agency, Amsterdam, the Netherlands, from 16/07/2019 to 18/07/2019, Last updated: 19/12/2019 -
List item
Joint Biologics Working Party / Quality Working Party workshop with stakeholders in relation to prior knowledge and its use in regulatory applications
European Medicines Agency, London, UK, 23/11/2017, Last updated: 04/04/2018 -
List item
Committee for Orphan Medicinal Products (COMP): 22-24 May 2018
European Medicines Agency, London, UK, from 22/05/2018 to 24/05/2018, Last updated: 17/08/2018 -
List item
Committee for Orphan Medicinal Products (COMP): 7-9 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 07/09/2021 to 09/09/2021, Last updated: 06/06/2017 -
List item
News: European Medicines Agency and US Food and Drug Administration release first conclusions of parallel assessment of quality-by-design applications
CHMP, Last updated: 20/08/2013 -
List item
Press release: European Medicines Agency confirms positive benefit-risk balance of MabThera
CHMP, Last updated: 25/05/2012 -
List item
Press release: European Medicines Agency gives final recommendations for 12 centrally authorised medicines manufactured at Ben Venue Laboratories
CHMP, Last updated: 16/02/2012 -
List item
Press release: European Medicines Agency starts review of Gilenya (fingolimod)
CHMP, Last updated: 20/01/2012 -
List item
Press release: European Medicines Agency advises doctors treating patients with nosocomial pneumonia with Doribax
CHMP, Last updated: 22/06/2012 -
List item
Press release: European Medicines Agency recommends contraindications for suppositories containing terpenic derivatives
CHMP, Last updated: 23/09/2011 -
List item
Press release: European Medicines Agency recommends transfer of manufacturing sites for Caelyx and Ceplene
CHMP, Last updated: 16/03/2012 -
List item
Committee for Orphan Medicinal Products (COMP): 11-13 July 2016
European Medicines Agency, London, UK, from 11/07/2016 to 13/07/2016, Last updated: 17/06/2014 -
List item
Committee for Orphan Medicinal Products (COMP): 5-6 December 2012
European Medicines Agency, London, UK, from 05/12/2012 to 06/12/2012, Last updated: 31/08/2011